Accelerating patient access to innovative treatments that improve quality of life
ICON’s Real World Intelligence™ approach – real world data (RWD) plus advanced expertise – gives you the insights and tools to address the RWE demands of key stakeholders
Our access, commercialisation and communications teams deliver integrated strategies and tactical services for commercial and medical affairs teams, for support from early phase to end of life cycle
ICON Commercialisation & Outcomes delivers resources and expertise to identify, generate, synthesize and communicate evidence of treatment value and safety, to help regulators, payers, providers and patients make informed health decisions.
Our global epidemiologists and outcomes researchers uncover the best strategies and richest data sources to deliver deep insights into the real world use of your products.Explore
Correct study choice and effective execution are paramount to achieving your goals. We design and implement studies to collect real world data, with a focus on maximising the return on investment.Explore
We understand the unique requirements of managing late phase and post-market studies. Our innovative global research services hubs deliver end-to-end site and patient support and patient engagement.Explore
As the industry’s largest life sciences language services provider, we deliver translations, linguistic validations, and market dominant COA expertise.Explore
Our market access, pricing, reimbursement and communications experts deliver integrated solutions to communicate evidence to drive payer, provider and patient acceptance.Explore
Today’s regulatory landscape is complex and ever-changing. We deliver solutions built on 30+ years of experience navigating global regulatory requirements and emerging issues.Explore
ICON is the leading sponsor of Mapi Research Trust, a non-profit organisation dedicated to improving patients’ quality of life by facilitating access to patient-centered outcome informationExplore
Read our white paper for insights on how ICON uses Real World Intelligence to drive evidence generation.